Filing Details

Accession Number:
0001144204-10-019877
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-13 13:00:00
Reporting Period:
2010-04-05
Filing Date:
2010-04-13
Accepted Time:
2010-04-13 17:11:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1038977 S Michael Weiss 787 7Th Avenue
48Th Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-04-05 290,100 $3.58 1,768,167 No 4 S Direct
Common Stock Acquisiton 2010-04-05 200,000 $1.30 1,968,167 No 4 M Direct
Common Stock Disposition 2010-04-12 150,000 $4.12 1,818,167 No 4 S Direct
Common Stock Acquisiton 2010-04-12 150,000 $1.30 1,968,167 No 4 M Direct
Common Stock Disposition 2010-04-13 20,100 $4.80 1,948,067 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct